Opella

Founded: 2019 • Age: 7 yrs Acquired By CD&R
Medicines and personal care products are distributed globally by Opella.
Request Access

About Opella

Opella is a company founded in 2019 was acquired by CD&R in October 2024.. Opella offers products and services including OTC Products, VMS Products, and Self-Care Brands. Opella operates in a competitive market with competitors including Cardinal Health, ACG Associated Capsules, Dvijay Pharma, Nu Sri Shyam Pharmaceuticals and Kapbro Pharma, among others.

  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Opella Oü
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $27.35 K (USD)
    22
    as on Dec 31, 2023
  • Net Profit
    $25.97 K (USD)
    24
    as on Dec 31, 2023
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    CD&R

    (Oct 21, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Opella

Opella offers a comprehensive portfolio of products and services, including OTC Products, VMS Products, and Self-Care Brands. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Over-the-counter items for everyday self-care and health needs

Vitamins and minerals supporting daily wellness and nutrition

Branded solutions for simple health management and prevention

Funding Insights of Opella

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Opella

Opella has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CD&R. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
A private equity firm focused on building long-term business value.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Opella

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Opella

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Opella Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Opella

Opella operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, ACG Associated Capsules, Dvijay Pharma, Nu Sri Shyam Pharmaceuticals and Kapbro Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple healthcare products and services are provided to organizations.
domain founded_year HQ Location
A distributor specializing in gelatin capsules for pharmaceutical applications.
domain founded_year HQ Location
Serves as a distributor of specialty drugs.
domain founded_year HQ Location
Distributes anti-HIV, life-saving, and anti-cancer medicines to hospitals and patients.
domain founded_year HQ Location
Distributes super-speciality and general pharmaceuticals to chemists, hospitals, and patients.
domain founded_year HQ Location
Distributor and retailer of oncology medicines with partnerships in healthcare.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Opella

Frequently Asked Questions about Opella

When was Opella founded?

Opella was founded in 2019.

Who is the current CEO of Opella?

Julie Van Ongevalle is the current CEO of Opella.

What is the annual revenue of Opella?

Annual revenue of Opella is $27.35K as on Dec 31, 2023.

What does Opella do?

Opella was founded in 2019 as a distributor in the over-the-counter medicines, vitamins, minerals, and supplements sector. Operations focus on a global portfolio that includes well-known brands such as Allegra, Buscopan, Doliprane, Dulcolax, Enterogermina, Essentiale, and Mucosolvan. Leadership is provided by CEO and President Julie Van Ongevalle, with activities centered on product distribution and manufacturing support across international markets.

Who are the top competitors of Opella?

Opella's top competitors include Cardinal Health, Dvijay Pharma and ACG Associated Capsules.

What products or services does Opella offer?

Opella offers OTC Products, VMS Products, and Self-Care Brands.

Who are Opella's investors?

Opella has 1 investor. Key investors include CD&R.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available